Sentry Investment Management’s Quest Diagnostics DGX Stock Holding History

Sentry Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-462	Closed	-$80K	–	135
2025 Q4	$80K	Hold	462	–	–	0.05%	276
2025 Q3	$84K	Buy	462 +111	+32%	+$19.7K	0.06%	267
2025 Q2	$61K	Hold	351	–	–	0.03%	362
2025 Q1	$58K	Sell	351 -105	-23%	-$17.2K	0.04%	339
2024 Q4	$69K	Sell	456 -74	-14%	-$11.5K	0.03%	359
2024 Q3	$82K	Buy	+530	New	+$79.2K	0.03%	371
2023 Q4	–	Sell	-646	Closed	-$79K	–	478
2023 Q3	$79K	Sell	646 -115	-15%	-$15.3K	0.04%	395
2023 Q2	$107K	Hold	761	–	–	0.04%	372
2023 Q1	$108K	Hold	761	–	–	0.04%	349
2022 Q4	$119K	Hold	761	–	–	0.05%	339
2022 Q3	$93K	Hold	761	–	–	0.04%	366
2022 Q2	$101K	Sell	761 -148	-16%	-$20.2K	0.05%	364
2022 Q1	$124K	Sell	909 -153	-14%	-$21.3K	0.04%	391
2021 Q4	$184K	Buy	+1,062	New	+$162K	0.05%	338
2021 Q2	–	Sell	-1,462	Closed	-$188K	–	510
2021 Q1	$188K	Sell	1,462 -7,002	-83%	-$863K	0.05%	332
2020 Q4	$1.01M	Hold	8,464	–	–	0.05%	305
2020 Q3	$969K	Hold	8,464	–	–	0.05%	281
2020 Q2	$965K	Sell	8,464 -17,984	-68%	-$1.91M	0.06%	299
2020 Q1	$2.12M	Buy	26,448 +23,403	+769%	+$2.42M	0.16%	153
2019 Q4	$325K	Hold	3,045	–	–	0.02%	420
2019 Q3	$326K	Hold	3,045	–	–	0.02%	407
2019 Q2	$310K	Sell	3,045 -4,985	-62%	-$479K	0.02%	444
2019 Q1	$722K	Sell	8,030 -713	-8%	-$61.8K	0.05%	340
2018 Q4	$728K	Sell	8,743 -229	-3%	-$21.5K	0.05%	329
2018 Q3	$968K	Hold	8,972	–	–	0.06%	300
2018 Q2	$986K	Sell	8,972 -999	-10%	-$104K	0.06%	292
2018 Q1	$1M	Sell	9,971 -957	-9%	-$98K	0.06%	312
2017 Q4	$1.08M	Hold	10,928	–	–	0.06%	312
2017 Q3	$1.02M	Buy	10,928 +575	+6%	+$61K	0.04%	316
2017 Q2	$1.15M	Hold	10,353	–	–	0.05%	292
2017 Q1	$1.02M	Sell	10,353 -504	-5%	-$48K	0.04%	316
2016 Q4	$998K	Buy	10,857 +2,895	+36%	+$250K	0.04%	318
2016 Q3	$674K	Hold	7,962	–	–	0.03%	402
2016 Q2	$648K	Hold	7,962	–	–	0.03%	410
2016 Q1	$569K	Hold	7,962	–	–	0.03%	425
2015 Q4	$566K	Buy	7,962 +1,160	+17%	+$78K	0.03%	422
2015 Q3	$418K	Hold	6,802	–	–	0.02%	416
2015 Q2	$493K	Hold	6,802	–	–	0.02%	429
2015 Q1	$523K	Hold	6,802	–	–	0.02%	409
2014 Q4	$456K	Hold	6,802	–	–	0.02%	415
2014 Q3	$413K	Sell	6,802 -838	-11%	-$51.6K	0.02%	429
2014 Q2	$448K	Sell	7,640 -560	-7%	-$32.8K	0.02%	432
2014 Q1	$475K	Sell	8,200 -1,800	-18%	-$96.5K	0.03%	423
2013 Q4	$535K	Hold	10,000	–	–	0.03%	396
2013 Q3	$618K	Buy	10,000 +1,800	+22%	+$108K	0.04%	349
2013 Q2	$497K	Buy	+8,200	New	+$488K	0.03%	308

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Sentry Investment Management's DGX Position: Q1 2026 in Review

Sentry Investment Management sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 462 shares — an estimated $80K sold.

Sentry Investment Management first reported a position in DGX in Q2 2013 and held it in 46 quarters. The position peaked at $2.12M in Q1 2020. 1,067 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Sentry Investment Management reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Sentry Investment Management sold 462 Quest Diagnostics shares in Q1 2026, an estimated $80K.
Sentry Investment Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 46 quarters.
Sentry Investment Management's Quest Diagnostics position peaked at $2.12M in Q1 2020.
1,067 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.